Several studies have pointed out that Gal3 is strongly associated with poor outcomes, such as new onset atrial fibrillation (demonstrated at levels greater than 16 ng/mL), left ventricle (LV) remodeling, heart failure and all-cause mortality [152,154,155,156]. The gene discussed is LGALS3; the disease is atrial fibrillation.